Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

First Baseline Data by REACH Supports and Extends ESC’s Euroaspire Findings

18.01.2006


While there are clear guidelines about the best way to treat cardiovascular risk factors such as high blood pressure and high cholesterol, the first large scale global study on cardiac care has revealed that there is a gap between what is recommended and what is practiced worldwide.



The study, published in the Journal of the American Medical Association (JAMA)(1), analyzes information collected by the Reduction of Atherothrombosis for Continued Health (REACH) Registry, the world’s largest international database of patients with established atherothrombrosis or with a constellation of risk factors. REACH includes more than 67,800 heart patients, treated by more than 5,400 physicians in 44 countries.

More than 14% of all patients in the REACH registry are current tobacco users; 40% are overweight; 27% are obese and 44% have diabetes – all of which are emerging as major contributors to aggressive cardiovascular disease. It is interesting to note that the study revealed Europeans as well as North Americans are overweight or obese.


The European Society of Cardiology’s (ESC) Euroaspire I and II surveys (2) clearly indicated that cardiovascular risk factors are insufficiently managed in people with proven coronary disease in hospitals in Europe. REACH extends the Euroaspire findings in post MI European patients to include other groups of patients (patients in primary care, patients with cerebrovascular disease or peripheral arterial disease) and to other regions of the world (Asia, Middle East, Latin America).

“The REACH study has substantial implications for the prevention of cardiovascular diseases,” said Professor Ian M. Graham, chairman of the ESC Joint European Societies Cardiovascular Prevention Committee. “The major risk factors for atherothrombotic disease had been known for many years. What is deeply concerning from the REACH Study is that even patients with atherothrombotic disease continue to carry a very heavy burden of hypertension and hypercholesterolaemia. The findings validate the ESC’s explicit policy of total cardiovascular risk estimation and management, rather than focusing on single risk factors.”

The REACH study also revealed that the type of treatment patients received depended on the specialty of the physician. Cardiologists, for example, prescribed statins significantly more often than physicians with other specialties.

“The findings stress the need for the appropriate and judicious use of appropriate drugs, such as statins, anti-hypertensive drugs and anti-platelet agents,” said Professor Graham. “Above all, the findings indicate the urgent need to promote a cultural change that favours physical activity, the avoidance of being overweight and the consequent avoidance of diabetes, together with a culture that avoids tobacco. Such an approach would inevitably have beneficial consequences on blood pressure and blood cholesterol control.”

The study’s results underline the need for more comprehensive and wide-spread risk assessment. This is being facilitated by the 4th Joint Task Force guidelines on prevention which, through the participation of the European Stroke initiative, will address the prevention of stroke as well as coronary heart and peripheral vascular disease. Guidance without practical implementation is of limited value, and the ESC’S Joint Prevention Committee is developing strategies to facilitate the dissemination and implementation of the Task Force guidelines.

The ESC is working on Euroaspire III (3), the third round of a risk factor management audit within Europe. Euroaspire III will extend into primary care and will study the management of risk factors in whole families in more detail, as well as evaluate the managements of risk factors in stroke subjects.

“There is huge potential to reduce the global burden of cardiovascular disease by encouraging a culture of physical activity, avoidance of overweight, and avoidance of tobacco, together with increased detection and better management of risk factors,” said Professor Graham. “The European Society of Cardiology, through its mission statement, is dedicated to facilitating these changes.”

(1) JAMA, January 11, 2006 - Vol 295, No. 2

(2) The Euroaspire I survey was undertaken by the Working Group on Epidemiology and Prevention of the European Society of Cardiology in 9 European countries. For more information see: http://www.escardio.org/knowledge/ehs/survey/previous_research_projects.htm

Euroaspire II’s goal was to understand the how effectively patients’ risk factors were being managed in comparison to the goals for coronary prevention set out in the 1998 Joint European Societies Recommendations on Coronary Prevention in Clinical Practice and are published in the European Heart Journal. http://www.escardio.org/knowledge/ehs/survey/EUROASPIREII.htm

(3) Eurospire III This third multi-centre European study will identify risk factors in coronary patients, their blood relatives and high risk individuals in the healthy population and describe their management. For more information see; http://www.escardio.org/knowledge/ehs/survey/

Lisa Abdolian | alfa
Further information:
http://www.escardio.org/vpo/press_releases/

More articles from Health and Medicine:

nachricht Oxygen can wake up dormant bacteria for antibiotic attacks
08.12.2016 | Penn State

nachricht NTU scientists build new ultrasound device using 3-D printing technology
07.12.2016 | Nanyang Technological University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Closing the carbon loop

08.12.2016 | Life Sciences

Applicability of dynamic facilitation theory to binary hard disk systems

08.12.2016 | Physics and Astronomy

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D

08.12.2016 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>